1165 København K
Tlf: 21 17 95 65 (man-fre kl. 9-15)
webinar — This is part of an ongoing webinar series in collaboration between International Federation of Pharma Manufacturers Associations (IFPMA) and University of Copenhagen, Faculty of Law, and administered by Center for Advanced Studies in Biomedical Innovation Law (CeBIL).
Date & Time:
Online via Zoom
International Federation of Pharma Manufacturers Associations (IFPMA) and Center for Advanced Studies in Biomedical Innovation Law (CeBIL)
The increasing importance of Artificial Intelligence, algorithms and Big Data in healthcare and life sciences has been a dominating feature in both law and policy discussions of late.
Clinical AI tools have shown promise in predicting health trajectories of patients, recommending treatments, guiding surgical care, monitoring patients, and supporting population health management (i.e., efforts to improve the health outcomes of a community). Other types of AI, such as administrative AI tools have shown promise in reducing provider burden and increasing efficiency by recording digital notes, optimizing operational processes.